These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 11606408)

  • 1. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    Bellamy WT; Richter L; Frutiger Y; Grogan TM
    Cancer Res; 1999 Feb; 59(3):728-33. PubMed ID: 9973224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer.
    Marshall CJ; Moore RL; Thorogood P; Brickell PM; Kinnon C; Thrasher AJ
    Dev Dyn; 1999 Jun; 215(2):139-47. PubMed ID: 10373018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis.
    Chute JP; Muramoto GG; Dressman HK; Wolfe G; Chao NJ; Lin S
    Stem Cells; 2006 May; 24(5):1315-27. PubMed ID: 16373696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of hematopoietic stem cells on mice vascular endothelial cells of diabetic retinopathy].
    Tian B; Li XX; Shen L; Zhao M; Yan Z; Dong JQ; Yu WZ
    Zhonghua Yan Ke Za Zhi; 2006 Sep; 42(9):818-24. PubMed ID: 17173744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
    Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
    Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential.
    Danet GH; Luongo JL; Butler G; Lu MM; Tenner AJ; Simon MC; Bonnet DA
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10441-5. PubMed ID: 12140365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
    Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.
    Yao M; Fouillard L; Lemoine FM; Bouchet S; Firat H; Andreu G; Gorin NC; Douay L; Lopez M
    Bone Marrow Transplant; 2000 Sep; 26(5):497-503. PubMed ID: 11019838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.
    Bertolini F; Dell'Agnola C; Mancuso P; Rabascio C; Burlini A; Monestiroli S; Gobbi A; Pruneri G; Martinelli G
    Cancer Res; 2002 Jun; 62(11):3106-12. PubMed ID: 12036921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.
    Kunkel P; Ulbricht U; Bohlen P; Brockmann MA; Fillbrandt R; Stavrou D; Westphal M; Lamszus K
    Cancer Res; 2001 Sep; 61(18):6624-8. PubMed ID: 11559524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.